1 Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty - 643001, The Nilgiris, Tamil Nadu, India
2 Department of Pharmacognosy & Phytopharmacy, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty - 643001, Nilgiris, Tamil Nadu, India
* Corresponding Author: Dr. S. Ponnusankar, Professor & Head, Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty - 643001, The Nilgiris, Tamil Nadu, India. Email: ponnusankarsivas@gmail.com | ORCID: 0000-0001-5589-090X | Contact: 9489613428
ORCID IDs: J. Jayaseelan: 0009-0006-2446-0564 | Shyam Nikethen: 0009-0000-6945-3647 | S.P. Dhanabal: 0000-0002-6244-6070 | S. Ponnusankar: 0000-0001-5589-090X
Contact Numbers: Jayaseelan: 9176619072 | Shyam Nikethen: 9626045884 | S.P. Dhanabal: 9489044577 | S. Ponnusankar: 9489613428
The pharmaceutical industry is changing based on digital technologies, with artificial intelligence (AI), blockchain, big data analytics, the Internet of Things (IoT), and telemedicine integrated to become more efficient, innovative, and provide better care to patients. The review was based on a bibliometric and narrative method according to PRISMA and included any literature published since 2000 in major databases, such as PubMed, Scopus, and Web of Science. They were visualized as thematic clusters, citation impact, and research trends with the help of VOSviewer, SciVal, and R-based network centrality analyses. Findings showed that digital health publications grew exponentially with three leading clusters that were AI-driven drug discovery, blockchain-based data traceability, and remote healthcare through telemedicine-enabled healthcare. This analysis has indicated the growing interdependence of clinical research, digital innovation and regulatory frameworks. Other challenges to the widespread adoption of blockchain technologies include data interoperability, privacy, scalability, and adaptation to regulations. It is discussed that global policies need to be unified, AI implementation must be ethical, and digital tools should be accessible to everyone. To sum up, the digital transformation is reformulating the science of pharmacology by joining technology to health provision, pushing the development of Pharma 4.0, a digital future in which predictive, personalized, and sustainable digital ecosystems will support the innovation and equity of health in the world.
Keywords: AI, IoT, VOSviewer, SciVal & R-based network.
How to cite this article: Yuvaraj J, Girivasan SN, Dhanabal SP, Ponnusankar S. A Global Bibliometric Analysis on Harnessing Digital Transformation in Pharmaceutical Industry. Int J Drug Deliv Technol. 2026;16(4): 153-166. DOI: 10.25258/ijddt.16.4.17
Source of support: Nil.
Conflict of interest: None